Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 463861 - 463880 out of 493148 entries
Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
---|---|---|---|---|---|---|---|---|
Switzerland | (L01CD02) docetaxel | Docetaxel Zentiva, Inf Konz 20 mg/1ml (alt), Durchstf 1 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
Head and Neck Neoplasms;Carcinoma, Non-Small-Cell Lung;Adenocarcinoma;Prostatic Neoplasms;Stomach Neoplasms;Breast Neoplasms | HelvepharmAG |
Switzerland | (L01CD02) docetaxel | Docetaxel Zentiva, Inf Konz 20 mg/1ml, Durchstf 1 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
Head and Neck Neoplasms;Carcinoma, Non-Small-Cell Lung;Adenocarcinoma;Prostatic Neoplasms;Stomach Neoplasms;Breast Neoplasms | HelvepharmAG |
Switzerland | (L01CD02) docetaxel | Docetaxel Zentiva, Inf Konz 80 mg/4ml (alt), Durchstf 1 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
Head and Neck Neoplasms;Carcinoma, Non-Small-Cell Lung;Adenocarcinoma;Prostatic Neoplasms;Stomach Neoplasms;Breast Neoplasms | HelvepharmAG |
Switzerland | (L01CD02) docetaxel | Docetaxel Zentiva, Inf Konz 80 mg/4ml, Durchstf 1 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
Head and Neck Neoplasms;Carcinoma, Non-Small-Cell Lung;Adenocarcinoma;Prostatic Neoplasms;Stomach Neoplasms;Breast Neoplasms | HelvepharmAG |
Switzerland | (L01CX) other plant alkaloids and natural products | abnobaVISCUM Fraxini, Inj Lös 0.02 mg, 8 Amp 1 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | FutureHealthPharmaGmbH |
Switzerland | (L01CX) other plant alkaloids and natural products | abnobaVISCUM Fraxini, Inj Lös 0.2 mg, 8 Amp 1 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | FutureHealthPharmaGmbH |
Switzerland | (L01CX) other plant alkaloids and natural products | abnobaVISCUM Fraxini, Inj Lös 2 mg, 8 Amp 1 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | FutureHealthPharmaGmbH |
Switzerland | (L01CX) other plant alkaloids and natural products | abnobaVISCUM Fraxini, Inj Lös 20 mg, 8 Amp 1 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | FutureHealthPharmaGmbH |
Switzerland | (L01DB01) doxorubicin | Caelyx, Inf Konz 20 mg/10ml, Amp 10 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | BaxterAG |
Switzerland | (L01DB01) doxorubicin | Doxorubicin Accord liposomal, Inf Konz 20 mg/10ml, Durchstf 1 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | AccordHealthcareAG |
Switzerland | (L01DB01) doxorubicin | Doxorubicin Accord liposomal, Inf Konz 50 mg/25ml, Durchstf 1 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | AccordHealthcareAG |
Switzerland | (L01DB01) doxorubicin | Doxorubicin Accord, Inj Lös 10 mg/5ml, Durchstf 1 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | AccordHealthcareAG |
Switzerland | (L01DB01) doxorubicin | Doxorubicin Accord, Inj Lös 100 mg/50ml, Durchstf 1 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | AccordHealthcareAG |
Switzerland | (L01DB01) doxorubicin | Adriblastin Sol, Inj Lös 20 mg/10ml, Cytosafe 10 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | PfizerAG |
Switzerland | (L01DB01) doxorubicin | Doxorubicin Accord, Inj Lös 20 mg/10ml, Durchstf 1 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | AccordHealthcareAG |
Switzerland | (L01DB01) doxorubicin | Doxorubicin Accord, Inj Lös 200 mg/100ml, Durchstf 1 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | AccordHealthcareAG |
Switzerland | (L01DB01) doxorubicin | Doxorubicin Accord, Inj Lös 50 mg/25ml, Durchstf 1 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | AccordHealthcareAG |
Switzerland | (L01EA06) asciminib (adm: O) | Scemblix, Filmtabl 20 mg, Blist 60 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisPharmaSchweizAG |
Switzerland | (L01EA06) asciminib (adm: O) | Scemblix, Filmtabl 40 mg, Blist 60 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisPharmaSchweizAG |
Switzerland | (L01FD02) pertuzumab | Perjeta, Inf Konz 420 mg/14 ml, Vial 14 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | RochePharma(Schweiz)AG |